| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |